Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PHVS Pharvaris > Detailed Quotes

PHVS Pharvaris

5.179
-0.206-3.83%
Trading Session 10/07 12:17 ET
High
5.650
Open
5.210
Turnover
37.93K
Low
5.000
Pre Close
5.385
Volume
7.16K
Market Cap
174.86M
P/E(TTM)
Loss
52wk High
27.500
Shares
33.77M
P/E(Static)
Loss
52wk Low
5.000
Float Cap
42.91M
Bid/Ask %
0.00%
Historical High
42.860
Shs Float
8.29M
Volume Ratio
0.46
Historical Low
5.000
Dividend TTM
--
Div Yield TTM
--
P/B
0.92
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.09%
Amplitude
12.07%
Avg Price
5.294
Lot Size
1
Float Cap
42.91M
Bid/Ask %
0.00%
Historical High
42.860
Shs Float
8.29M
Volume Ratio
0.46
Historical Low
5.000
Dividend TTM
--
P/B
0.92
Dividend LFY
--
Turnover Ratio
0.09%
Amplitude
12.07%
Avg Price
5.294
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Pharvaris NV operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. Its PHA121 program is designed to treat all sub-types of hereditary angioedema. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Hans Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.
CEO: Mr. Berndt Modig
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...